Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
clinical trials
deals
3
×
fda
3
×
life sciences
national blog main
national top stories
alnylam pharmaceuticals
bluebird bio
gene therapy
hemophilia
new york blog main
new york top stories
rna interference
spark therapeutics
achromatopsia
alexion pharmaceuticals
ambys medicines
amicus therapeutics
ampio pharmaceuticals
angelman syndrome
athenex
beta-thalassemia
bill cassidy
biomarin pharmaceutical
biotech
boehringer ingelheim
boston
boulder/denver blog main
boulder/denver top stories
centers for medicare & medicaid services
chris collins
competitive generic therapy
cystic fibrosis
detroit blog main
detroit top stories
dicerna pharamceuticals
dna
gout
What
gene
3
×
drug
therapy
age
aren’t
bigger
biggest
bio
caught
causing
come
deal
developers
dicerna
disease
drugs
emerging
eye
fda
gave
help
hepatitis
imminent
intended
j
johnson
long
medicare
medicines
meiragtx
morning
moves
news
noteworthy
past
patients
pay
pharma
pharmaceuticals
prices
Language
unset
Current search:
fda
×
deals
×
gene
×
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
5 years ago
With $100M MeiraGTx Deal, J&J Signals Bigger Move Into Gene Therapy
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More
